引用次数
引用: 811
H-指数: 9
I10-指数 : 8
出版物: 22
DYNAMICS OF A PREY-DEPENDENT DIGESTIVE MODEL WITH STATE-DEPENDENT IMPULSIVE CONTROL
LINNING QIAN , QISHAO LU , JIARU BAI , ZHAOSHENG FENG
International Journal of Bifurcation and Chaos 22 ( 04) 1250092
3
2012
Coordinating supply and demand on an on-demand service platform with impatient customers.(2018)
Jiaru BAI , Kut C SO , Christopher S TANG , Xiqun CHEN
Manufacturing and Service Operations Management 1 -15
Optimal Subsidy Schemes and Budget Allocations for Government‐Subsidized Trade‐in Programs
Luyi Gui , Kut C. So , Jiaru Bai , Zu‐Jun Ma
Production and Operations Management
11
2021
A Markov model to evaluate cost-effectiveness of the PARP inhibitor, olaparib, for fourth-line treatment of recurrent ovarian cancer.
Juliet Elizabeth Wolford , Jiaru Bai , Ramez Hassef Eskander , Robin Keller
Journal of Clinical Oncology 34 5563 -5563
2
2016
Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma.
Juliet E. Wolford , Jiaru Bai , Kathleen N. Moore , Rebecca Kristeleit
Gynecologic Oncology 157 ( 2) 500 -507
19
2020
Can Two Competing On-Demand Service Platforms be Profitable?
Jiaru Bai , Christopher S. Tang
Social Science Research Network
33
2018
A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
Lindsey E. Minion , Jiaru Bai , Bradley J. Monk , L. Robin Keller
Gynecologic Oncology 137 ( 3) 490 -496
45
2015
Cost-effectiveness of maintenance therapy in advanced ovarian cancer: Paclitaxel, bevacizumab, niraparib, rucaparib, olaparib, and pembrolizumab.
Juliet Elizabeth Wolford , Jiaru Bai , Lindsey E. Minion , Robin Keller
Journal of Clinical Oncology 36 5508 -5508
3
2018
Coordinating Supply and Demand on an On-Demand Service Platform with Impatient Customers
Jiaru Bai , Kut C. So , Christopher S. Tang , Xiqun (Michael) Chen
Manufacturing & Service Operations Management 21 ( 3) 556 -570
352
2019
Evaluating the cost-effectiveness of current FDA-approved PARP inhibitors for the treatment of recurrent ovarian cancer.
Juliet Elizabeth Wolford , Jiaru Bai , Ramez Hassef Eskander , Robin Keller
Journal of Clinical Oncology 35 5516 -5516
5
2017
SOLO1 versus SOLO2: Cost-effectiveness of olaparib as maintenance therapy for newly diagnosed and platinum-sensitive recurrent ovarian carcinoma among women with germline BRCA mutations (gBRCAmut).
Juliet Elizabeth Wolford , Krishnansu Sujata Tewari , Su-Ying Liang , Jiaru Bai
Journal of Clinical Oncology 37 5545 -5545
4
2019
Comparing Markov and non-Markov alternatives for cost-effectiveness analysis: Insights from a cervical cancer case
Cristina del Campo , Jiaru Bai , L. Robin Keller
Operations research for health care 21 32 -43
5
2019
A queueing model for managing small projects under uncertainties
Jiaru Bai , Kut C. So , Christopher Tang
European Journal of Operational Research 253 ( 3) 777 -790
7
2016
Concealing borrowers’ failure history in online P2P lending: A natural experiment
Jiaru Bai , Qiang Gao
Decision Sciences
2023
Time-based payout ratio for coordinating supply and demand on an on-demand service platform
Jiaru Bai , Kut C So , Christopher S Tang , Xiqun Chen
Sharing Economy: Making Supply Meet Demand 115 -136
3
2019
Coordinating Supply and Demand on an On-Demand Service Platform with Impatient
Jiaru Bai , K So , C Tang
2017
Markov Chain Models in Practice: A Review of Low Cost Software Options
Jiaru Bai , Cristina del Campo , L Robin Keller
Revista Investigación Operacional 38 ( 1) 56 -62
8
2017
Driver collusion in ride‐hailing platforms
Manish Tripathy , Jiaru Bai , H Sebastian Heese
Decision Sciences 54 ( 4) 434 -446
10
2023
Hiding in plain sight: Surge pricing and strategic providers
Jiaru Bai , H Sebastian Heese , Manish Tripathy
Production and Operations Management 32 ( 12) 3837 -3855
2023
Retail distribution strategy with outlet stores
Jiaru Bai , Haresh Gurnani , Shuya Yin
Production and Operations Management 31 ( 1) 281 -303
3
2022